3D spheroid assays
The development of efficient drug combinations for cancer therapy necessitates robust methods for testing drug efficacy. 3D cancer models, such as spheroids and tumoroids, are invaluable for cancer research and drug development due to their ability to closely mimic tumor structure and behavior. However, the complexity and manual nature of 3D assays have hindered their widespread adoption in high-throughput drug screening. The CellXpress.ai Automated Cell Culture System addresses these challenges by fully automating 3D spheroid assays, including plating, passaging, media exchanges, organoid monitoring, compound treatment, and endpoint assays. This automation significantly enhances the scalability, consistency, and efficiency of complex 3D cell-based assays, streamlining the discovery of new therapeutic targets and drug combinations.